Статья

HIV/SARS-CoV-2 coinfection: A global perspective

O. Kanwugu, P. Adadi,
2021

Since its first appearance in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread throughout the world and has become a global pandemic. Several medical comorbidities have been identified as risk factors for coronavirus disease 2019 (COVID-19). However, it remains unclear whether people living with human immunodefeciency virus (PLWH) are at an increased risk of COVID-19 and severe disease manifestation, with controversial suggestion that HIV-infected individuals could be protected from severe COVID-19 by means of antiretroviral therapy or HIV-related immunosuppression. Several cases of coinfection with HIV and SARS-CoV-2 have been reported from different parts of the globe. This review seeks to provide a holistic overview of SARS-CoV-2 infection in PLWH. © 2020 Wiley Periodicals LLC

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • O. Kanwugu
    Department of Technology for Organic Synthesis, Institute of Chemical Engineering, Ural Federal University, Yekaterinburg, Russian Federation
  • P. Adadi
    Department of Food Science, University of Otago, Dunedin, New Zealand
Название журнала
  • Journal of Medical Virology
Том
  • 93
Выпуск
  • 2
Страницы
  • 726-732
Ключевые слова
  • clinical feature; comorbidity; coronavirus disease 2019; disease association; disease severity; high income country; human; Human immunodeficiency virus 1 infection; infection risk; mixed infection; nonhuman; pandemic; Review; virus load; adult; CD4+ T lymphocyte; diabetes mellitus; drug effect; female; growth, development and aging; highly active antiretroviral therapy; Human immunodeficiency virus; Human immunodeficiency virus infection; hypertension; immunocompromised patient; immunology; male; middle aged; mixed infection; mortality; pandemic; pathogenicity; pathophysiology; survival analysis; treatment outcome; virology; anti human immunodeficiency virus agent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Coinfection; Comorbidity; COVID-19; Diabetes Mellitus; Female; HIV; HIV Infections; Humans; Hypertension; Immunocompromised Host; Male; Middle Aged; Pandemics; SARS-CoV-2; Survival Analysis; Treatment Outcome
Издатель
  • John Wiley and Sons Inc
Тип документа
  • Review
Источник
  • scopus